[{"AccountsPayableCurrent_0_Q2_USD":9242000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7932000.0,"MarketableSecuritiesCurrent_0_Q2_USD":77902000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":10725000.0,"AmortizationOfFinancingCosts_2_Q2_USD":712000.0,"AmortizationOfFinancingCosts_1_Q2_USD":356000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":6094000.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":3047000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11897000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7932000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":5250000.0,"OtherLiabilitiesCurrent_0_Q2_USD":1470000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":1115000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-731000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q2_USD":13200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":11897000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":3884000.0,"TreasuryStockValue_0_Q2_USD":2638000.0,"TreasuryStockShares_0_Q2_shares":51409.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":44000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":176000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":344000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":7800000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":8955000.0,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2_Q2_USD":199822000.0,"InterestExpenseDebt_2_Q2_USD":6806000.0,"InterestExpenseDebt_1_Q2_USD":3403000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-687000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":1291000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":157173000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":531574000.0,"DeferredRevenueCurrent_0_Q2_USD":158851000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_Q2_USD":5145000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":44000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.01,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":199822000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":411000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":106768000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":29750000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":107608000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":164204000.0,"OtherNoncashIncomeExpense_2_Q2_USD":1793000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":44000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":176000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-731000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":1115000.0,"LongTermDebtPercentageBearingFixedInterestRate_0_Q2_pure":0.0375,"InvestmentIncomeNet_2_Q2_USD":732000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q2_USD":2647000.0,"InvestmentIncomeNet_1_Q2_USD":297000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":70468000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":222000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":400000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":276000.0,"DeferredRevenueNoncurrent_0_Q2_USD":2500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":449394000.0,"BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_0_Q2_USD":1800000.0,"BusinessAcquisitionsProFormaRevenue_2_Q2_USD":38915000.0,"BusinessAcquisitionsProFormaRevenue_1_Q2_USD":35538000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_2_Q2_USD":-45821000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_1_Q2_USD":-18196000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":77902000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":77858000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-2773000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-44072000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16230000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":393763000.0,"Revenues_2_Q2_USD":38915000.0,"Revenues_1_Q2_USD":35538000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1499325000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":115375000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":393763000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":27316000.0,"NetIncomeLoss_1_Q2_USD":-17521000.0,"NetIncomeLoss_2_Q2_USD":-43385000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":92524000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-245946000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":602540000.0,"LiabilitiesCurrent_0_Q2_USD":213331000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":932227000.0,"Liabilities_0_Q2_USD":547879000.0,"StockholdersEquity_0_Q2_USD":184526000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":61079000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":17719000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.84,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.3,"CostsAndExpenses_2_Q2_USD":78839000.0,"CostsAndExpenses_1_Q2_USD":52565000.0,"CommonStockValue_0_Q2_USD":612000.0,"CommonStockSharesOutstanding_0_Q2_shares":61211223.0,"CommonStockSharesIssued_0_Q2_shares":61262632.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":424395000.0,"AssetsCurrent_0_Q2_USD":636381000.0,"Assets_0_Q2_USD":932227000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7797651.0,"AdditionalPaidInCapital_0_Q2_USD":1699072000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-13195000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":27098000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":58618000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51401000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":38690000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":207845000.0,"OtherAssetsNoncurrent_0_Q2_USD":55961000.0,"Goodwill_0_Q2_USD":118849000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":400000.0,"DebtInstrumentFaceAmount_0_Q2_USD":325000000.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q2_shares":10.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2753000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":2613000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":2612000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":5250000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":11599000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":27094000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":300000.0,"ShareBasedCompensation_2_Q2_USD":11897000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":600000000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":321323000.0,"DepreciationAndAmortization_2_Q2_USD":1905000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":6349000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":2000000.0,"InterestExpense_1_Q2_USD":3403000.0,"InterestPaidNet_2_Q2_USD":6094000.0,"InterestPayableCurrent_0_Q2_USD":5078000.0,"OperatingIncomeLoss_1_Q2_USD":-17027000.0,"OperatingIncomeLoss_2_Q2_USD":-39924000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":34846000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":51741000.0,"InterestExpense_2_Q2_USD":6806000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":3677000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]